Raymond James & Associates’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $22.8M | Buy |
805,080
+71,402
| +10% | +$2.02M | 0.01% | 746 |
|
|
2024
Q2 | $19.3M | Sell |
733,678
-50,871
| -6% | -$1.34M | 0.01% | 796 |
|
|
2024
Q1 | $23.8M | Buy |
784,549
+560,897
| +251% | +$17M | 0.02% | 694 |
|
|
2023
Q4 | $6.28M | Buy |
+223,652
| New | +$6.28M | ﹤0.01% | 1379 |
|
|
2023
Q1 | – | Sell |
-7,240
| Closed | -$286K | – | 3902 |
|
|
2022
Q4 | $286K | Sell |
7,240
-7,388
| -51% | -$292K | ﹤0.01% | 3227 |
|
|
2022
Q3 | $588K | Buy |
14,628
+2,680
| +22% | +$108K | ﹤0.01% | 2747 |
|
|
2022
Q2 | $502K | Buy |
+11,948
| New | +$502K | ﹤0.01% | 2901 |
|
|
2020
Q3 | – | Sell |
-4,223
| Closed | -$205K | – | 3535 |
|
|
2020
Q2 | $205K | Buy |
+4,223
| New | +$205K | ﹤0.01% | 3102 |
|